Table 5.

Laboratory parameters.

Parameter	Group	Number of values	Minimum	25% percentile	Median	75% percentile	Maximum	Range	Mean	Std. deviation	Std. error of mean	p value
Creatinine (mg/dl)	HOx	14	0.21	0.25	0.34	0.54	18.5	18.29	2.08	5.0	1.34	0.8693
	noHOx	12	0.24	0.3	0.34	0.42	0.77	0.53	0.4	0.17	0.05
	Control group	50	0.25	0.31	0.38	0.45	0.86	0.61	0.4	0.12	0.017	0.5939 (to noHOx) 0.5705 (to HOx)
eGFR (ml/min/1.73 m2)	HOx	12	2.2	105	129.3	156.7	186.9	184.7	115.7	58.17	16.79	0.2773
	noHOx	9	77.49	91.83	104.5	127.2	158.5	81.04	110.2	25.26	8.42
	Control group	28	87.29	108.3	119.2	142	162.6	75.31	123.9	21.08	3.98	0.1164 (to noHOx) 0.8729 (to HOx)
Urinary oxalate (mmol/mol creatinine)	HOx	12	43.8	116	124.5	211	283	239.2	148.3	69.55	20.08	0 . 0018
	noHOx	12	5.5	16	39	65.25	155	149.5	52.13	48.65	14.04
	SBS (all)	24	5.5	32.7	98.5	139.5	283	277.5	100.2	76.54	15.62	0 . 0017
	Control group	50	14.1	26.3	38.85	52.55	98.7	84.6	40.73	17.77	2.51
Urinary citrate (mmol/mol creatinine)	HOx	10	11.9	105.9	235.5	505.8	842	830.1	318.2	277.5	87.75	0.7361
	noHOx	12	0.79	32.25	221	612.8	1,521	1,520	376.4	466.7	134.7
Urinary calcium (mol/mol creatinine)	HOx	12	0	0.34	0.62	1.07	3.67	3.67	0.952	1.04	0.3	0.8874
	noHOx	12	0.1	0.27	0.58	1.64	2.37	2.27	0.9	0.76	0.22

HOx, patients with hyperoxaluria; noHOx, patients without hyperoxaluria; SBS (all), all patients with short bowel syndrome.

Bold values highlight statistical significance (p < 0.05).